CVE-2019-6540
lowPriorität · verfolgen · 26OT-Risiko · erhöhtEPSS 0.002 · 9. PerzentilEUUSEPSS · bewertet 2026-10-28
The Conexus telemetry protocol utilized within Medtronic MyCareLink Monitor versions 24950 and 24952, CareLink Monitor version 2490C, CareLink 2090 Programmer, Amplia CRT-D, Claria CRT-D, Compia CRT-D, Concerto CRT-D, Concerto II CRT-D, Consulta CRT-D, Evera ICD, Maximo II CRT-D and ICD, Mirro ICD, Nayamed ND ICD, Primo ICD, Protecta ICD and CRT-D, Secura ICD, Virtuoso ICD, Virtuoso II ICD, Visia AF ICD, and Viva CRT-D does not implement encryption. An attacker with adjacent short-range access to a target product can listen to communications, including the transmission of sensitive data.
Behebungen
Hersteller-Fix, Mitigation oder Workaround, wie von den Quellen veröffentlicht.
Ein Hersteller-Fix ist verfügbar.
- BehobenAmplia CRT-Dcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenBrava CRT-Dcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenCareLink 2090 Programmercisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenCareLink Monitorcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenClaria CRT-Dcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenCompia CRT-Dcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenConcerto CRT-Dcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenConcerto II CRT-Dcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenConsulta CRT-Dcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenEvera ICDcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenMaximo II CRT-D and ICDcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenMirro ICDcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenMirro MRI ICDcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenMyCareLink Monitorcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenNayamed ND ICDcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenPrimo ICDcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenProtecta ICD and CRT-Dcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenSecura ICDcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenVirtuoso ICDcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenVirtuoso II ICDcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenVisia AF ICDcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
- BehobenViva CRT-Dcisa_csaf_ot
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
cvss
Technischer Schweregrad, 0–10. Eine Zeile je Quelle.
Basiswert 0–10 · höher = schwerwiegender · Vektor überfahren zum Auflösen⚠ Quellen uneinig · low–medium · 3.3–6.5
schwächen
Die CWE-Schwächeklassen, zu denen dies gehört.
betroffene Produkte (92)
Betroffene Produkte und Versionsbereiche.
Advisories (1)
Hersteller- und Ökosystem-Meldungen dazu.
- ICSMA-19-080-01Medtronic Conexus Radio Frequency Telemetry Protocol (Update C)2019-03-21icsa · cisa_csaf_otUS
Successful exploitation of these vulnerabilities may allow an attacker with adjacent short-range access to one of the affected products to interfere with, generate, modify, or intercept the radio frequency (RF) communication of the Medtronic proprietary Conexus telemetry system, potentially impacting product functionality and/or allowing access to transmitted sensitive data. Successful exploitation requires: (1) an RF device capable of transmitting or receiving Conexus telemetry communication, such as a monitor, programmer, or software-defined radio (SDR); (2) to have adjacent short-range access to the affected products; and (3) for the products to be in states where the RF functionality is active. Before the device implant procedure and during follow-up clinic visits, the Conexus telemetry sessions require initiation by an inductive protocol. Outside of these use environments, the RF radio in the affected implanted device is enabled for brief periods of time to support scheduled follow-up transmissions and other operational and safety notifications. The result of successful exploitation of these vulnerabilities may include the ability to read and write any valid memory location on the affected implanted device and therefore impact the intended function of the device.
auch bekannt als (3)
Weitere Namen und Kennungen dieser Entität.
quellen
Welche Quellen diesen Datensatz belegen und wann.
Referenzen (12)
Externe Belege — Patches, Meldungen, Analysen.
- http://www.securityfocus.com/bid/107544cnnvd
- https://ics-cert.us-cert.gov/advisories/ICSMA-19-080-01cnnvd
- https://nvd.nist.gov/vuln/detail/CVE-2019-6540cnnvd
- https://us-cert.cisa.gov/ics/advisories/ICSMA-19-080-01cnnvd
- https://www.auscert.org.au/bulletins/77634cnnvd
- https://www.auscert.org.au/bulletins/ESB-2019.0950.2/cnnvd
- https://www.securityfocus.com/bid/107544cnnvd
- https://www.us-cert.gov/ics/advisories/ICSMA-19-080-01cnnvd
Angreifer nutzen Schwachstellen wie diese gegen im Internet exponierte Dienste aus. Sehen Sie mit einem kostenlosen Passiv-Scan, was exponiert ist.
Kostenloser Scan